MDxHealth has been listed on Euronext since 2006 and on NASDAQ since 2021. There is only one class of shares in the company (common shares) and all shares have the same rights and voting representation. Other than American Depositary Shares (ADSs) listed on Nasdaq (each representing ten common shares) and stock options issued to employees, directors, and some consultants, there are no other financial instruments issued by the company.
The company reports its consolidated financial statements under International Financial Reporting Standards (IFRS) and all amounts are in US Dollars. MDxHealth publishes a consolidated and audited Annual Report on an annual basis, a consolidated Interim Report for its June 30 half-year financial figures, and business/financial updates at the end of Q1 and Q3.
News for Investors
MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings and Resignation of Director
MDxHealth annonce les résultats de ses assemblées générales ordinaire et extraordinaire des actionnaires et la démission d’un administrateur
Palmetto GBA’s MolDX Issues Foundational LCD Covering the Indication for SelectMDx for Prostate Cancer